Table: Noile-Immune Biotech -2023 parent results

Noile-Immune Biotech

13/02/2024 07:55

Feb 13 (Reuters)- 
          Noile-Immune Biotech Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2023    Dec 31, 2022   Dec 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          316 mln         625 mln                               
               (-49.3 pct)                                             
  Operating   loss 775 mln    loss 106 mln                             
  Recurring     loss 1.13     loss 384 mln                             
  Net           loss 1.13     loss 386 mln                             
  EPS        loss 27.25 yen   loss 9.87 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T